Literature DB >> 14679492

Variation of peak inspiratory flow through dry powder inhalers in children with stable and unstable asthma.

Arvid W A Kamps1, Paul L P Brand, Ruurd Jan Roorda.   

Abstract

Drug release from dry powder inhalers depends for a large part on a sufficiently high peak inspiratory flow (PIF). We determined the variation of PIF through two commonly prescribed dry powder inhalers in children with asthma. We analyzed the effect of inhaler device, age, and severity of asthma symptoms on variation of PIF. Fifty-eight children with asthma (4-15 years old) recorded PIF values together with asthma symptoms in a diary twice daily for 4 weeks. PIF was measured with a portable PIF-meter (In-Check) equipped with adapters to simulate flow resistance through the Accuhaler and Turbohaler inhalers. Children generated higher PIF values through an Accuhaler adapter than through a Turbohaler adapter (95% CI for difference, 25.7-31.7). Mean PIF values increased with age, independent of type of inhaler. The mean (SD) variation of PIF (low%high) was 72.3 (8.1)% for patients using the Accuhaler adapter, and 67.0 (14.5)% for patients using the Turbohaler adapter (mean difference, 5.2%; 95% CI, -0.9 to 11.4). Children < or =7 years of age had a significantly greater variation of PIF in addition to a lower mean PIF (P = 0.0003). PIF decreased significantly when symptoms of asthma increased (mean maximal decrease 11 l/min; P < 0.01), but the correlation between PIF and morning and evening symptoms was weak (r = -0.18 and r = -0.16, respectively). Patients who reported moderate or severe symptoms during the study period had a significantly greater variation of PIF compared to patients who remained free of symptoms or reported mild symptoms. The majority of patients generated PIF >30 l/min during the study, even when they experienced symptoms of asthma. The variation of PIF through the Accuhaler and Turbohaler adapter was significantly greater for children < or =7 years of age and for patients experiencing moderate or severe symptoms of asthma. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14679492     DOI: 10.1002/ppul.10410

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  6 in total

Review 1.  The Impact of Inspiratory Flow Rate on Drug Delivery to the Lungs with Dry Powder Inhalers.

Authors:  Jeffry Weers; Andy Clark
Journal:  Pharm Res       Date:  2016-10-13       Impact factor: 4.200

2.  Effect of inhaler design variables on paediatric use of dry powder inhalers.

Authors:  Anne J Lexmond; Tonnis J Kruizinga; Paul Hagedoorn; Bart L Rottier; Henderik W Frijlink; Anne H de Boer
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

Review 3.  The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates.

Authors:  Andrew R Clark; Jeffry G Weers; Rajiv Dhand
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-10-31       Impact factor: 2.849

Review 4.  Essential Role of Pharmacists in Asthma Care and Management.

Authors:  Mary B Bridgeman; Lori A Wilken
Journal:  J Pharm Pract       Date:  2020-06-04

5.  Performance of dry powder inhalers with single dosed capsules in preschool children and adults using improved upper airway models.

Authors:  Sandra Lindert; Antje Below; Joerg Breitkreutz
Journal:  Pharmaceutics       Date:  2014-02-06       Impact factor: 6.321

6.  Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza.

Authors:  Toshiki Murasaka; Kenji Ikemura; Tomoyuki Enokiya; Yuichi Muraki; Mayumi Ikemura; Koji Terada; Takuya Iwamoto; Masahiro Okuda
Journal:  J Pharm Health Care Sci       Date:  2017-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.